These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 1900555)

  • 1. [Should cost benefit analysis be done when new routines are introduced?].
    Bäck E
    Lakartidningen; 1991 Feb; 88(9):720-2. PubMed ID: 1900555
    [No Abstract]   [Full Text] [Related]  

  • 2. [All blood donors should be tested to stop the transmission of hepatitis C virus].
    Högman C; Iwarson S; Lindholm A; Nordenfelt E; Weiland O
    Lakartidningen; 1990 Aug; 87(34):2555-6. PubMed ID: 2120521
    [No Abstract]   [Full Text] [Related]  

  • 3. [Is it worth its price?].
    Bäck E
    Lakartidningen; 1991 Mar; 88(10):842. PubMed ID: 1901125
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum pooling for screening of blood donors for hepatitis C virus antibody.
    Kini S; Kumar S; Sharma RR; Thakral B; Agnihotri SK
    Indian J Pathol Microbiol; 2003 Jul; 46(3):537-8. PubMed ID: 15025337
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prevention for hepatitis C virus transmission].
    Sekiguchi S
    Hokkaido Igaku Zasshi; 1993 Jul; 68(4):473-6. PubMed ID: 7687974
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antibodies to hepatitis B core antigen in blood donors and hepatitis non-A, non-B in blood recipients].
    Sugg U
    Beitr Infusionsther; 1988; 21():177-81. PubMed ID: 2462972
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hepatitis C virus (HCV) antibodies in German blood donors--a pilot study].
    Seidl S; Kühnl P; Beyer J; Stangel W; Flik J; Sibrowski W; Roos D; Bornhövd K; Kalmar G; Flacke H
    Beitr Infusionsther; 1990; 26():18-21. PubMed ID: 2177676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Medical and economic evaluation of donated blood screening for hepatitis C and non-A, non-B, non-C hepatitis].
    Vergnon P; Colin C; Jullien AM; Bory E; Excoffier S; Matillon Y; Trepo C
    Rev Epidemiol Sante Publique; 1996 Jan; 44(1):66-79. PubMed ID: 8851944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening blood donations for HCV.
    Maclennan S; Barbara JA; Hewitt P; Moore C; Contreras M
    Lancet; 1992 Jan; 339(8785):131-2. PubMed ID: 1345863
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
    Chung HT; Lee JS; Lok AS
    Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis of a hypothetical hepatitis C vaccine compared to antiviral therapy.
    Massad E; Coutinho FA; Chaib E; Burattini MN
    Epidemiol Infect; 2009 Feb; 137(2):241-9. PubMed ID: 18631422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Post-transfusional hepatitis].
    González A; Esteban JI
    Sangre (Barc); 1993 Jun; 38(3):193-200. PubMed ID: 7692610
    [No Abstract]   [Full Text] [Related]  

  • 13. [Post-transfusion viral hepatitis].
    Katayama T
    Rinsho Byori; 1991 Mar; Suppl 88():156-70. PubMed ID: 1906949
    [No Abstract]   [Full Text] [Related]  

  • 14. Elective cesarean delivery to prevent perinatal transmission of hepatitis C virus: a cost-effectiveness analysis.
    Plunkett BA; Grobman WA
    Am J Obstet Gynecol; 2004 Sep; 191(3):998-1003. PubMed ID: 15467579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of screening and complementary tests for anti-HCV antibodies].
    Głoskowska-Moraczewska Z; Kacperska E; Seyfried H
    Acta Haematol Pol; 1993; 24(3):273-80. PubMed ID: 7504386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility and cost-benefit of implementing pooled screening for HCVAg in small blood bank settings.
    Sarov B; Novack L; Beer N; Safi J; Soliman H; Pliskin JS; Litvak E; Yaari A; Shinar E
    Transfus Med; 2007 Dec; 17(6):479-87. PubMed ID: 17727618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfusion-transmitted diseases: current problems and challenges.
    Bove JR
    Prog Hematol; 1986; 14():123-47. PubMed ID: 3003795
    [No Abstract]   [Full Text] [Related]  

  • 18. Liver disease and HCV infection after transplantation of organs from hepatitis C antibody positive donors.
    Pereira BJ; Milford EL; Kirkman RL; Quan S; Sayre KR; Johnson PJ; Wilber JC; Levey AS
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1458-9. PubMed ID: 7680160
    [No Abstract]   [Full Text] [Related]  

  • 19. Microbiological screening of blood donations: cost versus effectiveness.
    Barbara JA
    Med Lab Sci; 1989 Jul; 46(3):250-4. PubMed ID: 2514335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to hepatitis C virus: a cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery.
    García-Bengoechea M; Emparanza JI; Sarriugarte A; Cortés A; Vega JL; González F; Arenas JI
    Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):237-41. PubMed ID: 7538032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.